112904-74-2 Usage
Pharmaceutical properties
Potential use in preventing migraine headaches, treating vertigo and Parkinson's disease
Mechanism of action
Calcium channel blocker
Potential effects
Reducing frequency and severity of migraines, reducing number of vertigo attacks, improving symptoms related to movement disorders
Investigated for
Potential neuroprotective effects in conditions such as ischemic stroke and neurodegenerative diseases
Check Digit Verification of cas no
The CAS Registry Mumber 112904-74-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,2,9,0 and 4 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 112904-74:
(8*1)+(7*1)+(6*2)+(5*9)+(4*0)+(3*4)+(2*7)+(1*4)=102
102 % 10 = 2
So 112904-74-2 is a valid CAS Registry Number.
InChI:InChI=1/C15H23NO2/c1-3-8-16(9-4-2)13-10-12-6-5-7-14(17)15(12)18-11-13/h5-7,13,17H,3-4,8-11H2,1-2H3
112904-74-2Relevant articles and documents
Methoxy and hydroxy derivatives of 3,4-dihydro-3-(di-n-propylamino)-2H-1-benzopyrans: New synthesis and dopaminergic activity
Al Neirabeyeh,Reynaud,Podona,Ou,Perdicakis,Coudert,Guillaumet,Pichat,Gharib,Sarda
, p. 497 - 504 (2007/10/02)
The synthesis of methoxy and hydroxy derivatives of 3,4-dihydro-3-(di-n-propylamino)-2H-1-benzopyran from readily available or commercial o-hydroxybenzaldehydes is described in six steps. The enantiomers of 8-hydroxy-3,4-dihydro-3-(di-n-propyl-amino)-2H-1-benzopyran 1b have been resolved. It is shown that the compound (-)-1b is a mroe selective D-2 agonist, compared to apomorphine.